Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Precancerous Conditions 1

Interventions

Selenium 4Epoetin Alfa 3Vitamin E 2Darbepoetin alfa 2Aminolevulinic Acid 2tirbanibulin 1human papillomavirus vaccine, L1 type 16, 18 1ferrous sulfate 1ferric gluconate 1alpha-Tocopherol 1Watchful Waiting 1Vaginal Smears 1Toremifene 1Sulindac 1Sucrose 1Soybean Proteins 1Rosuvastatin Calcium 1Radiotherapy, Intensity-Modulated 1Polymerase Chain Reaction 1Ondansetron 1Morphine 1Light Coagulation 1Imiquimod 1Hypericum extract LI 160 1Fenretinide 1Esomeprazole 1Eflornithine 1Early Intervention, Educational 1Dextromethorphan 1Deoxyribonuclease (Pyrimidine Dimer) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Precancerous Conditions × Polymerase Chain Reaction × Clear all
NCT00462813 2013-08-07

Diindolylmethane in Treating Patients With Abnormal Cervical Cells

National Cancer Institute (NCI)

Phase 3 Completed
3,000 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡